News
Only use certain shots free of an ingredient antivaccine groups have falsely tied to autism, the advisers said.
MilliporeSigma Announces Neoclease as Winner of 2025 North American Advance Biotech Grant - BioSpace
The company has awarded 40+ startups globally through Advance Biotech Grant since 2014 BURLINGTON, Mass.-- (BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, ...
Merck's (NYSE:MRK) top-selling drug – Keytruda's – impressive recent growth tells a compelling story, but it's one with a predictable ending. The pharmaceutical giant's remarkable performance ...
Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond its cancer drugs and vaccines.
The Association for Materials Protection and Performance (AMPP), the leading global authority in materials protection and performance, in collaboration with the American Water Works Association (AWWA) ...
Merck (NYSE:MRK) recently initiated the IDeate-Prostate01 phase 3 trial, dosing the first patient for its investigational drug ifinatamab deruxtecan, aimed at treating metastatic castration ...
Merck KGaA (ETR:MRK) has had a rough three months with its share price down 16%. But if you pay close attention, you might gather that its strong financials could mean that the stock could ...
Editor’s note: This story was updated at 8:47 a.m. June 19, 2025, to note that Merck Manuals – a separate entity from Merck – launched the new tool.
Merck gets lift from U.S. patent office in battle over injectable form of Keytruda Dispute with Halozyme Therapeutics could affect plans to extend its franchise product Adobe By Ed Silverman June ...
Merck to Participate in the 46th Annual Goldman Sachs Global Healthcare ConferenceRAHWAY, N.J.-- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results